Allosteric Regulation
Allosteric Sites and Conformational Changes
Most enzymes don't just respond to substrate concentration. They also respond to other signals in the cell through allosteric regulation, where effector molecules bind at allosteric sites (sites distinct from the active site). This binding induces conformational changes that propagate through the protein structure, reshaping the active site to either enhance or inhibit catalytic activity.
The result is that allosteric enzymes can be fine-tuned in real time based on metabolic demands. For example, when a pathway's end product accumulates, it can allosterically inhibit an enzyme early in that pathway, preventing wasteful overproduction. This kind of feedback is central to how cells maintain homeostasis.

Homotropic and Heterotropic Effects
Allosteric effects are classified by what is doing the binding:
- Homotropic effects occur when the substrate itself acts as the allosteric effector. Binding of substrate at one subunit influences the affinity of other subunits for that same substrate. Hemoglobin is the classic example: when one subunit binds , it increases the affinity of the remaining subunits for . This is cooperative binding driven by a homotropic effect.
- Heterotropic effects involve molecules other than the substrate binding at allosteric sites. These effectors can be activators or inhibitors:
- Activators stabilize the high-affinity (R) state of the enzyme. For instance, calcium ions activating calmodulin-dependent enzymes.
- Inhibitors stabilize the low-affinity (T) state. A well-known example is ATP inhibiting phosphofructokinase-1 (PFK-1) in glycolysis, signaling that the cell already has plenty of energy.

Cooperativity
Positive and Negative Cooperativity
Cooperativity describes how ligand binding at one site of a multi-subunit protein affects binding affinity at other sites. It only occurs in proteins with multiple binding sites (typically oligomeric proteins).
- Positive cooperativity: binding of a ligand at one site increases the affinity at remaining sites. Each successive binding event becomes easier. This produces a sigmoidal (S-shaped) binding curve rather than the hyperbolic curve you'd see with independent binding. Hemoglobin is the textbook case: the first is hardest to bind, and the fourth is easiest. This sigmoidal behavior lets hemoglobin load efficiently in the lungs (high ) and release it efficiently in tissues (low ).
- Negative cooperativity: binding of a ligand at one site decreases the affinity at remaining sites. Each successive binding event becomes harder. This flattens the binding curve relative to a standard hyperbolic curve, making the protein less sensitive to large swings in ligand concentration. Some forms of glyceraldehyde-3-phosphate dehydrogenase display negative cooperativity.
Hill Coefficient and Sigmoidal Kinetics
The Hill coefficient () quantifies the degree of cooperativity. It comes from the Hill equation:
where is the fraction of occupied binding sites and is ligand concentration. Plotting versus gives a Hill plot, and the slope of the linear region is .
How to interpret the Hill coefficient:
- : positive cooperativity
- : negative cooperativity
- : no cooperativity (each site binds independently, giving standard Michaelis-Menten hyperbolic kinetics)
For enzymes with positive cooperativity, the sigmoidal kinetics curve has a steep transition zone around (the ligand concentration at half-maximal activity, analogous to ). A higher Hill coefficient means a steeper curve and a more switch-like response: small changes in substrate concentration near produce large changes in enzyme activity. This is why allosteric enzymes with positive cooperativity are so effective as regulatory control points in metabolic pathways. They can toggle between nearly off and nearly on over a narrow concentration range.